相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ezetimibe Ameliorates Metabolic Disorders and Microalbuminuria in Patients with Hypercholesterolemia
Shusuke Yagi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Gastrointestinal regulatory peptides and their effects on fat tissue
Ishita D. Majumdar et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
Yuichi Nozaki et al.
JOURNAL OF HEPATOLOGY (2009)
Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8
Weiqing Tang et al.
JOURNAL OF LIPID RESEARCH (2009)
The core gut microbiome, energy balance and obesity
Peter J. Turnbaugh et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice
Eric D. Labonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice
Weiqing Tang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Transcriptional Regulation of HMG-CoA Synthase and HMG-CoA Reductase Genes by Human ACBP
Christina Vock et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2008)
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
Shuqin Zheng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Extracellular loop C of NPC1L1 is important for binding to ezetimibe
Adam B. Weinglass et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
Michiyo Deushi et al.
FEBS LETTERS (2007)
Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetirnibe
Ryan E. Temel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Expression of the rat sterol regulatory element-binding protein-1c gene in response to insulin is mediated by increased transactivating capacity of specificity protein 1 (Sp1)
Xiong Deng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Deficiency of Niemann-Pick C1 like 1 prevents atherosclerosis in ApoE-/- mice
Harry R. Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Plasma cholesterol is hyperresponsive to statin in ABCG5/ABCG8 transgenic mice
Weiqing Tang et al.
HEPATOLOGY (2006)
Localization and role of NPC1L1 in cholesterol absorption in human intestine
Alain Theophile Sane et al.
JOURNAL OF LIPID RESEARCH (2006)
Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease
Nimer Assy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: A post hoc analysis of subpopulations from three pooled clinical trials
Theodore Feldman et al.
CLINICAL THERAPEUTICS (2006)
Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake
LQ Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels
JC Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
M Watanabe et al.
NATURE (2006)
Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment
JS Simon et al.
GENOMICS (2005)
The target of ezetimibe is Niemann-Pick Cl-Like 1 (NPC1L1)
M Garcia-Calvo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
LXRs regulate the balance between fat storage and oxidation
NY Kalaany et al.
CELL METABOLISM (2005)
Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia
JP Davies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The gut and energy balance: Visceral allies in the obesity wars
MK Badman et al.
SCIENCE (2005)
Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe
J Wang et al.
CLINICAL GENETICS (2005)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis
HR Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A novel, noninvasive method for the measurement of intestinal fat absorption
RJ Jandacek et al.
GASTROENTEROLOGY (2004)
ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse: Impact on hepatic cholesterol homeostasis
JJ Repa et al.
HEPATOLOGY (2004)
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia
HE Bays et al.
CLINICAL THERAPEUTICS (2004)
Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors
JA Tobert
NATURE REVIEWS DRUG DISCOVERY (2003)
Sterol absorption by the small intestine
SD Turley et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia
MH Davidson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Efficacy and safety of Ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
C Gagné et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Inhibition of intestinal cholesterol absorption by ezetimibe in humans
T Sudhop et al.
CIRCULATION (2002)
Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β
JJ Repa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice
HR Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene
J Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs
HR Davis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function
M van Heek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters
M van Heek et al.
DIABETES (2001)
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys
M van Heek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters
KE Berge et al.
SCIENCE (2000)
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
JJ Repa et al.
GENES & DEVELOPMENT (2000)
Evidence for a Niemann-Pick C (NPC) gene family: Identification and characterization of NPC1L1
JP Davies et al.
GENOMICS (2000)
Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
JJ Repa et al.
SCIENCE (2000)
分享论文
